Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer.

MLA

Li, Yang, et al. “Plasma THBS1 as a Predictive Biomarker for Poor Prognosis and Brain Metastasis in Patients with HER2-Enriched Breast Cancer.” International Journal of Clinical Oncology, vol. 29, no. 4, Apr. 2024, pp. 427–41. EBSCOhost, https://doi.org/10.1007/s10147-024-02472-9.

APA

Li, Y., Qin, J., Chen, G., Wu, W., & Sun, X. (2024). Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer. International Journal of Clinical Oncology, 29(4), 427–441. https://doi.org/10.1007/s10147-024-02472-9

Chicago

Li, Yang, Jun Qin, Guiming Chen, Weidong Wu, and Xing Sun. 2024. “Plasma THBS1 as a Predictive Biomarker for Poor Prognosis and Brain Metastasis in Patients with HER2-Enriched Breast Cancer.” International Journal of Clinical Oncology 29 (4): 427–41. doi:10.1007/s10147-024-02472-9.